1. Home
  2. THRY vs TNYA Comparison

THRY vs TNYA Comparison

Compare THRY & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

HOLD

Current Price

$3.72

Market Cap

170.3M

Sector

Industrials

ML Signal

HOLD

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

HOLD

Current Price

$0.73

Market Cap

171.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRY
TNYA
Founded
2012
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.3M
171.4M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
THRY
TNYA
Price
$3.72
$0.73
Analyst Decision
Buy
Strong Buy
Analyst Count
4
3
Target Price
$9.33
$5.33
AVG Volume (30 Days)
917.2K
4.8M
Earning Date
04-30-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
100.50
54.96
EPS
0.10
N/A
Revenue
$785,015,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$38.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.91
$0.53
52 Week High
$14.28
$2.35

Technical Indicators

Market Signals
Indicator
THRY
TNYA
Relative Strength Index (RSI) 51.35 40.54
Support Level $3.46 $0.65
Resistance Level $4.17 $0.82
Average True Range (ATR) 0.29 0.07
MACD -0.01 -0.01
Stochastic Oscillator 43.32 3.07

Price Performance

Historical Comparison
THRY
TNYA

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable small and medium-sized business clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation. The group has two business segments; Thryv SaaS deriving maximum revenue and Thryv Marketing Services.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: